Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
Katharina S. Schmitz, Daryl Geers, Rory D. de Vries, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 16

Showing 16 citing articles:

Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity
Saïd Mougari, Valérie Favède, Camilla Predella, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Viral Membrane Fusion: A Dance Between Proteins and Lipids
Judith M. White, Amanda E. Ward, Laura Odongo, et al.
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 139-161
Open Access | Times Cited: 35
Lipopeptides development in cosmetics and pharmaceutical applications: A comprehensive review
Melania Pilz, Philipp Cavelius, Farah Qoura, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108210-108210
Open Access | Times Cited: 15
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development
Ariel J. Kuhn, Victor K. Outlaw, Tara C. Marcink, et al.
Journal of Virology (2025)
Open Access
Pan‐coronavirus fusion inhibitors to combat COVID‐19 and other emerging coronavirus infectious diseases
Qiaoshuai Lan, Lijue Wang, Fanke Jiao, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 22
Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages
Enya Qing, Tom Gallagher
mBio (2023)
Open Access | Times Cited: 8
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides
Yuanmei Zhu, Yue Hu, Nian Liu, et al.
Antiviral Research (2022) Vol. 208, pp. 105445-105445
Open Access | Times Cited: 12
Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate
Rui Su, Jin Zeng, Tara C. Marcink, et al.
ACS Central Science (2023) Vol. 9, Iss. 6, pp. 1213-1228
Open Access | Times Cited: 7
Virus-mediated cell fusion of SARS-CoV-2 variants
Ava Amidei, Hana M. Dobrovolny
Mathematical Biosciences (2024) Vol. 369, pp. 109144-109144
Closed Access | Times Cited: 1
Advancements in the Development of Anti-SARS-CoV-2 Therapeutics
Junjie Huang, Qianqian Ma, Zhengding Su, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10820-10820
Open Access | Times Cited: 1
Chemically modified antiviral peptides against SARS‐CoV‐2
Michael Quagliata, Anna Maria Papini, Paolo Rovero
Journal of Peptide Science (2023)
Open Access | Times Cited: 2
Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters
Kim Handrejk, Katharina S. Schmitz, Edwin J. B. Veldhuis Kroeze, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Serum of Interferon Lambda-1 level as a protein biomarker for the diagnosis of COVID-19 severity
Shakir Abdulridha Abbas, Hanaa Addai Ali, Rawaa Ali, et al.
Current Issues in Pharmacy and Medical Sciences (2024) Vol. 37, Iss. 4, pp. 200-207
Open Access
SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization
Enya Qing, Julisa Salgado, Alexandria Wilcox, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012757-e1012757
Open Access
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein
Hongliang Jin, Lin Cheng, Yani Gong, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 1
Page 1

Scroll to top